Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2020

Segment Reporting

Schedule of reportable operating segment information

	CareVention HealthCare		MedWise HealthCare		Consolidated
Revenue:
Three Months Ended June 30, 2020
Product revenue	$	38,930	$	443	$	39,373
Service revenue
PACE solutions		11,522		—		11,522
Medication safety services		—		15,707		15,707
Software subscription and services		—		10,232		10,232
Total service revenue		11,522		25,939		37,461
Total revenue	$	50,452	$	26,382	$	76,834
Three Months Ended June 30, 2019
Product revenue	$	33,372	$	—	$	33,372
Service revenue
PACE solutions		11,437		—		11,437
Medication safety services		—		22,498		22,498
Software subscription and services		—		8,948		8,948
Total service revenue		11,437		31,446		42,883
Total revenue	$	44,809	$	31,446	$	76,255
Six Months Ended June 30, 2020
Product revenue	$	76,017	$	443	$	76,460
Service revenue
PACE solutions		23,093		—		23,093
Medication safety services		—		30,027		30,027
Software subscription and services		—		20,081		20,081
Total service revenue		23,093		50,108		73,201
Total revenue	$	99,110	$	50,551	$	149,661
Six Months Ended June 30, 2019
Product revenue	$	64,354	$	—	$	64,354
Service revenue
PACE solutions		22,611		—		22,611
Medication safety services		—		37,849		37,849
Software subscription and services		—		12,400		12,400
Total service revenue		22,611		50,249		72,860
Total revenue	$	86,965	$	50,249	$	137,214

	CareVention HealthCare		MedWise HealthCare		Shared Services		Consolidated
Adjusted EBITDA (loss):
Three Months Ended June 30, 2020
Adjusted EBITDA (loss)	$	12,077	$	4,697	$	(9,640)	$	7,134
Three Months Ended June 30, 2019
Adjusted EBITDA (loss)	$	11,466	$	9,059	$	(6,873)	$	13,652
Six Months Ended June 30, 2020
Adjusted EBITDA (loss)	$	23,825	$	7,528	$	(19,412)	$	11,941
Six Months Ended June 30, 2019
Adjusted EBITDA (loss)	$	22,086	$	10,707	$	(13,450)	$	19,343

Schedule of reconciliation of the segments? total Adjusted EBITDA to net loss

	Three Months Ended June 30,				Six Months Ended June 30,
	2020		2019		2020		2019
Reconciliation of net loss to Adjusted EBITDA
Net loss	$	(14,310)	$	(6,529)	$	(28,747)	$	(17,508)
Add:
Interest expense, net		4,668		4,308		9,278		7,001
Income tax benefit		(508)		(2,539)		(3,875)		(6,580)
Depreciation and amortization		10,211		9,078		20,124		15,377
Change in fair value of acquisition-related contingent consideration (income) expense		(100)		1,830		600		3,006
Acquisition-related expense		—		598		251		4,289
Stock-based compensation expense		7,173		6,906		14,310		13,758
Adjusted EBITDA	$	7,134	$	13,652	$	11,941	$	19,343